Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infection

Vincent Thibault (1, 2, 3)

1 EHESP - École des Hautes Études en Santé Publique [EHESP]
2 Irset - Institut de recherche en santé, environnement et travail
3 CHU Pontchaillou [Rennes]

[No abstract available]

Keywords: hepatitis B surface antigen; interferon; ribavirin; cancer recurrence; chronic hepatitis C; end stage liver disease; hepatitis B; Hepatitis B virus; human; immune response; immunosuppressive treatment; liver cell carcinoma; meta analysis (topic); microenvironment; nonhuman; Note; outcome assessment; priority journal; protein expression; serology; viral clearance; virus reactivation; signal transduction

Domains: Life Sciences [q-bio]; Ecology, environment; Health

Vincent Thibault. Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infection. The Lancet Gastroenterology & Hepatology, 2018, 3 (3), pp.145-147. ⟨10.1016/S2468-1253(18)30004-9⟩. ⟨hal-01730831⟩